Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.58M Buy
+4,359
New +$1.49M 0.46% 67
2023
Q3
Sell
-5,912
Closed -$1.31M 116
2023
Q2
$1.31M Buy
+5,912
New +$1.37M 0.63% 58
2018
Q1
Sell
-17,616
Closed -$3.06M 193
2017
Q4
$3.06M Buy
+17,616
New +$3.12M 2.25% 22

Other funds holding AMGN

G&S Capital's AMGN Position: Q2 2026 in Review

G&S Capital opened a new position in Amgen (AMGN) in Q2 2026: 4,359 shares worth $1.58M. The stake represents 0.46% of the portfolio and ranks #67 among its holdings. This is a return to the name: G&S Capital previously reported a position in AMGN as recently as Q2 2023.

G&S Capital first reported a position in AMGN in Q4 2017 and has held it in 3 quarters since. The position peaked at $3.06M in Q4 2017. 659 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • G&S Capital held 4,359 shares of Amgen worth $1.58M as of Q2 2026.
  • Amgen was a new G&S Capital position in Q2 2026.
  • Amgen made up 0.46% of G&S Capital's portfolio in Q2 2026, its #67 holding.
  • G&S Capital first reported a position in Amgen in Q4 2017 and has held it in 3 quarters since.
  • G&S Capital's Amgen position peaked at $3.06M in Q4 2017.
  • 659 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.